CD24Fc ameliorates immune-related adverse events while preserving anti-tumor therapeutic effect
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Publishing Group
2022-07-01
|
| Series: | Signal Transduction and Targeted Therapy |
| Online Access: | https://doi.org/10.1038/s41392-022-01030-x |
| _version_ | 1811294624989315072 |
|---|---|
| author | Mingyue Liu Xu Wang Xuexiang Du Yan Zhang Chunxia Ai Siwen Hu-Lieskovan Tianhong Li Martin Devenport Yang Liu Pan Zheng |
| author_facet | Mingyue Liu Xu Wang Xuexiang Du Yan Zhang Chunxia Ai Siwen Hu-Lieskovan Tianhong Li Martin Devenport Yang Liu Pan Zheng |
| author_sort | Mingyue Liu |
| collection | DOAJ |
| first_indexed | 2024-04-13T05:20:13Z |
| format | Article |
| id | doaj.art-69c64d5ac5e942fab6522563e2d84be9 |
| institution | Directory Open Access Journal |
| issn | 2059-3635 |
| language | English |
| last_indexed | 2024-04-13T05:20:13Z |
| publishDate | 2022-07-01 |
| publisher | Nature Publishing Group |
| record_format | Article |
| series | Signal Transduction and Targeted Therapy |
| spelling | doaj.art-69c64d5ac5e942fab6522563e2d84be92022-12-22T03:00:47ZengNature Publishing GroupSignal Transduction and Targeted Therapy2059-36352022-07-01711310.1038/s41392-022-01030-xCD24Fc ameliorates immune-related adverse events while preserving anti-tumor therapeutic effectMingyue Liu0Xu Wang1Xuexiang Du2Yan Zhang3Chunxia Ai4Siwen Hu-Lieskovan5Tianhong Li6Martin Devenport7Yang Liu8Pan Zheng9Division of Immunotherapy, Institute of Human Virology and Department of Surgery, University of Maryland School of MedicineDivision of Immunotherapy, Institute of Human Virology and Department of Surgery, University of Maryland School of MedicineDivision of Immunotherapy, Institute of Human Virology and Department of Surgery, University of Maryland School of MedicineDivision of Immunotherapy, Institute of Human Virology and Department of Surgery, University of Maryland School of MedicineDivision of Immunotherapy, Institute of Human Virology and Department of Surgery, University of Maryland School of MedicineDivision of Oncology, Huntsman Cancer Institute, University of Utah School of MedicineDivision of Hematology/Oncology, Department of Internal Medicine, University of California Davis School of Medicine, University of California Davis Comprehensive Cancer CenterOncoC4, IncDivision of Immunotherapy, Institute of Human Virology and Department of Surgery, University of Maryland School of MedicineDivision of Immunotherapy, Institute of Human Virology and Department of Surgery, University of Maryland School of Medicinehttps://doi.org/10.1038/s41392-022-01030-x |
| spellingShingle | Mingyue Liu Xu Wang Xuexiang Du Yan Zhang Chunxia Ai Siwen Hu-Lieskovan Tianhong Li Martin Devenport Yang Liu Pan Zheng CD24Fc ameliorates immune-related adverse events while preserving anti-tumor therapeutic effect Signal Transduction and Targeted Therapy |
| title | CD24Fc ameliorates immune-related adverse events while preserving anti-tumor therapeutic effect |
| title_full | CD24Fc ameliorates immune-related adverse events while preserving anti-tumor therapeutic effect |
| title_fullStr | CD24Fc ameliorates immune-related adverse events while preserving anti-tumor therapeutic effect |
| title_full_unstemmed | CD24Fc ameliorates immune-related adverse events while preserving anti-tumor therapeutic effect |
| title_short | CD24Fc ameliorates immune-related adverse events while preserving anti-tumor therapeutic effect |
| title_sort | cd24fc ameliorates immune related adverse events while preserving anti tumor therapeutic effect |
| url | https://doi.org/10.1038/s41392-022-01030-x |
| work_keys_str_mv | AT mingyueliu cd24fcamelioratesimmunerelatedadverseeventswhilepreservingantitumortherapeuticeffect AT xuwang cd24fcamelioratesimmunerelatedadverseeventswhilepreservingantitumortherapeuticeffect AT xuexiangdu cd24fcamelioratesimmunerelatedadverseeventswhilepreservingantitumortherapeuticeffect AT yanzhang cd24fcamelioratesimmunerelatedadverseeventswhilepreservingantitumortherapeuticeffect AT chunxiaai cd24fcamelioratesimmunerelatedadverseeventswhilepreservingantitumortherapeuticeffect AT siwenhulieskovan cd24fcamelioratesimmunerelatedadverseeventswhilepreservingantitumortherapeuticeffect AT tianhongli cd24fcamelioratesimmunerelatedadverseeventswhilepreservingantitumortherapeuticeffect AT martindevenport cd24fcamelioratesimmunerelatedadverseeventswhilepreservingantitumortherapeuticeffect AT yangliu cd24fcamelioratesimmunerelatedadverseeventswhilepreservingantitumortherapeuticeffect AT panzheng cd24fcamelioratesimmunerelatedadverseeventswhilepreservingantitumortherapeuticeffect |